Lionco Pharmaceutical Group Co.,Ltd. (603669.SS) SHH

4.99

-0.02(-0.40%)

Updated at December 05 11:29AM

Currency In CNY

Valuation

Market Cap3.79B
Enterprise Value3.79B
P/E Ratio-29.66
PEG Ratio-5.63
Price/Sales Ratio8.37
Price/Book Ratio4.77
Enterprise/Revenue8.63
Enterprise/EBITDA-47.6

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-0.28
Operating Margin-0.27

Management Effectiveness

Return On Assets-0.1
Return On Equity-0.16

Income Statement

Revenue379.78M
Revenue/Share0.61
Gross Profit178.04M
EBITDA-64.01M
Net Income-130.76M
Diluted EPS-0.18

Balance Sheet

Total Cash191.32M
Total Cash/Share0.27
Total Debt284.64M
Total Debt/Equity0.39
Current Ratio3.11
Book Value Per Share1.05

Price History

52-Week Change-37.63
52-Week High9.54
52-Week Low3.45
Moving Average 50 Days5.49
Moving Average 200 Days5.28

Statistics

Average Volume11.75M
Shares Outstanding721.25M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.05
Last Split Factor7:5
Last Split DateMay 26, 2020